Holen Sie sich die Stockscreener-App
202.41
0.01%
-0.03
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics (NYSE:DGX) SVP Sells $196,227.14 in Stock - MarketBeat
Quest Diagnostics (NYSE:DGX) EVP Sells $293,521.39 in Stock - MarketBeat
Insider Selling: Quest Diagnostics (NYSE:DGX) SVP Sells 1,111 Shares of Stock - MarketBeat
A diagnostics company moved out. Its former landlord claims it left a mess. - The Business Journals
Quest Diagnostics Incorporated $DGX Stock Holdings Boosted by Vanguard Group Inc. - MarketBeat
First National Bank of Omaha Invests $8.83 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Advisors Capital Management LLC Acquires 14,258 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Skandinaviska Enskilda Banken AB publ Sells 27,243 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Piper Sandler Adjusts Price Target on Quest Diagnostics to $215 From $200, Maintains Neutral Rating - marketscreener.com
Do Wall Street Analysts Like Quest Diagnostics Stock? - Barchart.com
5 Insightful Analyst Questions From Quest's Q4 Earnings Call - Finviz
Cibc World Market Inc. Increases Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
M&G PLC Has $208.26 Million Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Sold by ABN Amro Investment Solutions - MarketBeat
Rhumbline Advisers Decreases Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
ING Groep NV Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Wall Street Recap: What analysts say about Quest Diagnostics Incorporated stock - baoquankhu1.vn
A Look At Quest Diagnostics (DGX) Valuation After Strong Results, 2026 Outlook, Buybacks And New Myeloma Test - Yahoo Finance
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.86 - Yahoo Finance
Quest Diagnostics Incorporated $DGX Shares Sold by Cookson Peirce & Co. Inc. - MarketBeat
Quest Diagnostics (DGX): Analyst Raises Price Target to $235 | D - GuruFocus
Mizuho Securities Adjusts Quest Diagnostics PT to $235 From $210, Maintains Outperform Rating - marketscreener.com
Rothschild & Co Redburn Adjusts Quest Diagnostics PT to $224 From $200, Maintains Buy Rating - marketscreener.com
Forecasting The Future: 6 Analyst Projections For Quest Diagnostics - Benzinga
DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds - Finviz
Quest Diagnostics (DGX): Truist Securities Raises Price Target A - GuruFocus
UBS Raises Price Target for Quest Diagnostics (DGX) to $210 | DG - GuruFocus
Deutsche Bank Adjusts Quest Diagnostics Price Target to $205 From $178, Maintains Hold Rating - marketscreener.com
DGX: Evercore ISI Group Raises Price Target for Quest Diagnostics | DGX Stock News - GuruFocus
Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency - FinancialContent
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Evercore ISI Adjusts Quest Diagnostics PT to $220 From $190, Maintains In Line Rating - marketscreener.com
Barclays Adjusts Quest Diagnostics PT to $225 From $210, Maintains Overweight Rating - marketscreener.com
Baird Adjusts Quest Diagnostics Price Target to $219 From $203, Maintains Neutral Rating - marketscreener.com
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript - Insider Monkey
DGX: Jefferies Raises Target Price for Quest Diagnostics to $220 - GuruFocus
Truist Raises Price Target on Quest Diagnostics to $220 From $205, Keeps Hold Rating - marketscreener.com
Candriam S.C.A. Has $13.69 Million Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Shares Jump on Q4 Beat; FY25 Revenue Rises, 2026 Outlook Raised - AlphaStreet News
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MSN
Quest Diagnostics Q4 Earnings Call Highlights - Yahoo Finance
Jefferies Maintains Buy on Quest Diagnostics (DGX) Feb 10, 2026 - Meyka
Quest Diagnostics: Q4 Earnings Snapshot - theheraldreview.com
Why Is Quest (DGX) Stock Soaring Today - Finviz
Quest Diagnostics (DGX) Earnings Call Transcript - The Globe and Mail
Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: St - GuruFocus
Quest Diagnostics hits 52-week high as outlook tops consensus - MSN
Why Is Quest Diagnostics Stock Soaring Tuesday?Quest Diagnostics (NYSE:DGX) - Benzinga
Quest's (NYSE:DGX) Q4 CY2025: Beats On Revenue - Finviz
Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up - sharewise.com
Quest Diagnostics (DGX) Sees Significant Stock Price Surge - GuruFocus
Quest Diagnostics Incorporated announces an Increase in Equity Buyback - marketscreener.com
Quest Diagnostics Stock Gains 7% Over Increased Profit In Q4 - Nasdaq
Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. - marketscreener.com
Quest Diagnostics hits 52-week high on outlook (DGX:NYSE) - Seeking Alpha
Quest Diagnostics (NYSE:DGX) Sets New 12-Month High Following Strong Earnings - MarketBeat
Quest Diagnostics stock hits all-time high at $198.00 By Investing.com - Investing.com Canada
Quest Diagnostics stock hits all-time high at $198.00 - Investing.com
Quest Diagnostics Seeks Independent Lab Acquisitions - marketscreener.com
Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand - marketscreener.com
Quest Diagnostics (NYSE:DGX) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
Quest Diagnostics Incorporated Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Quest Diagnostics (NYSE:DGX) Issues FY 2026 Earnings Guidance - MarketBeat
Quest Diagnostics: Fourth Quarter Earnings Overview - bitget.com
Quest Diagnostics Q4 Adjusted Earnings, Revenue Rise; 2026 Guidance Set -- Shares Up Pre-Bell - marketscreener.com
Quest Diagnostics Posts Strong 2025 Results, Boosts Shareholder Returns - TipRanks
0.07%
2.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):